All Photos(1)

Key Documents

COO/COA

View All Documentation

482641

(S)-(+)-2-Fluoro-α-methyl-4-biphenylacetic acid

Name: (<I>S</I>)-(+)-2-Fluoro-α-methyl-4-biphenylacetic acid
Brand: ALDRICH

98%

Synonym(s):

(S)-(+)-Flurbiprofen

Sign Into View Organizational & Contract Pricing

All Photos(1)

About This Item

Linear Formula:

C₆H₅C₆H₃(F)CH(CH₃)CO₂H

CAS Number:

51543-39-6

Molecular Weight:

244.26

EC Number:

257-263-1

MDL number:

MFCD00866152

UNSPSC Code:

12352000

PubChem Substance ID:

24871839

assay

98%

optical activity

[α]24/D +43°, c = 1 in chloroform

mp

109-110 °C (lit.)

SMILES string

C[C@H](C(O)=O)c1ccc(c(F)c1)-c2ccccc2

Gene Information

human ... IL8RA(3577)

pictograms

GHS06

signalword

Danger

hcodes

H301

pcodes

P301 + P310

Hazard Classifications

Acute Tox. 3 Oral

Storage Class

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.

Ilaria Peretto et al.

Journal of medicinal chemistry, 48(18), 5705-5720 (2005-09-02)

Flurbiprofen, a nonsteroidal antiinflammatory drug (NSAID), has been recently described to selectively inhibit beta-amyloid(1)(-)(42) (Abeta42) secretion, the most toxic component of the senile plaques present in the brain of Alzheimer patients. The use of this NSAID in Alzheimer's disease (AD)

2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.

Marcello Allegretti et al.

Journal of medicinal chemistry, 48(13), 4312-4331 (2005-06-25)

The CXC chemokine CXCL8/IL-8 plays a major role in the activation and recruitment of polymorphonuclear (PMN) cells at inflammatory sites. CXCL8 activates PMNs by binding the seven-transmembrane (7-TM) G-protein-coupled receptors CXC chemokine receptor 1 (CXCR1) and CXC chemokine receptor 2

The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer's disease modifying agent.

Nicholas Stock et al.

Bioorganic & medicinal chemistry letters, 16(8), 2219-2223 (2006-02-04)

The subtle modification of a selection of Abeta42 inhibiting non-steroidal anti-inflammatory drugs (NSAIDs), through synthesis of the geminal dimethyl analogues, was anticipated to ablate their cyclooxygenase activity whilst maintaining Abeta42 inhibition. Methylflurbiprofen 6 exhibited similar in vitro Abeta42 inhibition to

Hologram QSAR model for the prediction of human oral bioavailability.

Tiago L Moda et al.

Bioorganic & medicinal chemistry, 15(24), 7738-7745 (2007-09-18)

A drug intended for use in humans should have an ideal balance of pharmacokinetics and safety, as well as potency and selectivity. Unfavorable pharmacokinetics can negatively affect the clinical development of many otherwise promising drug candidates. A variety of in

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service